
|
Author of the Month
|
To sign up to the Graham Hancock newsletter mailing list, please click here.
The first gene therapy to be approved in the West will hit the market by the middle of next year, opening the masses to a controversial treatment that directly alters a patient’s own DNA. Dutch biotech uniQure’s Glybera was approved for sale by the European Commission late last month. |
Back to Previous...
Go to News Desk...
Enjoy the newsdesk? Please tell others about it:
TweetSite design by Amazing Internet Ltd, maintenance by Synchronicity. Site privacy policy. Contact us.
Dedicated Servers and Cloud Servers by Gigenet. Invert Colour Scheme / Default